Sign in

A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease.

B. TavernaA. CasonatoFabrizio BezzoFederico Galvanin
Published in: Comput. Methods Programs Biomed. (2019)
Keyphrases